Delamanid for Tuberculosis Approved in Europe, New Drugs Under Study
- Details
- Category: Tuberculosis (TB)
- Published on Wednesday, 28 May 2014 00:00
- Written by HIVandHepatitis.com
The European Union recently approved the new anti-tuberculosis drug delamanid (Deltyba) for use in combination therapy for people with multidrug-resistant TB. In related news, the Stop TB Partnership announced that it will make another new drug, bedaquiline (Sirturo), available in more than 100 low- and middle-income countries.
March 24 Is World TB Day
- Details
- Category: Tuberculosis (TB)
- Published on Friday, 21 March 2014 00:00
- Written by Liz Highleyman
Monday, March 24, is World TB Day, an opportunity to raise awareness about tuberculosis and the need for expanded testing and treatment worldwide. TB remains a threat in high-income countries including the U.S. as well as in resource-limited settings, and it is a major cause of death among people with HIV. The Stop TB Partnership estimates that 9 million people worldwide get sick with TB annually, but 3 million of them do not get the care they need.
Mass Screening, Prevention Did Not Improve TB Control in South African Trial
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 28 January 2014 00:00
- Written by London School of Hygiene and Tropical Medicine
Widespread screening for tuberculosis, treatment of people with active disease, and providing everyone with preventive isoniazid did not significantly improve tuberculosis (TB) control in a study of workers in South African gold mines, researchers reported in the January 23, 2014, New England Journal of Medicine.
CROI 2014: New Drugs, Novel Combos Top Tuberculosis News at Conference
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 18 March 2014 00:00
- Written by Theo Smart
Replacing 2 drugs in standard tuberculosis (TB) regimens may shorten therapy and experimental drugs look good in early studies, but a promising diagnostic test did not lead to improvements in mortality, researchers reported at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this month in Boston.
New Anti-TB Strategy Target: Elimination of the Disease
- Details
- Category: Tuberculosis (TB)
- Published on Thursday, 21 November 2013 00:00
- Written by Theo Smart
A major shift in the global anti-tuberculosis (TB) strategy was announced at the Stop TB Symposium just prior to the 44th Union World Conference on Lung Health this month in Paris. Instead of setting modest targets for incremental improvements in TB control, which has been the norm for the past few decades, the TB community -- clearly driven by TB/HIV activism -- is now calling for a global effort to eliminate the ancient disease.
More Articles...
- Preventive Antibiotics for Tuberculosis Lower Risk of Death for People with HIV
- HIV i-Base and TAG Release 2013 Pipeline Report on HIV, Hepatitis C, and TB Therapies
- Directly Observed Therapy for Tuberculosis No Better than Self-Administration
- Vitamin C Rapidly Kills Drug-resistant Tuberculosis Bacteria
Web Design and Development by